Key result
Sympathetic nerve activity varies during the ovarian cycle in healthy women not using oral contraceptives (17.3 vs 25.4 bursts/min, P<0.001), but this variation is blunted in OCP users.
Why the study?
Do oral contraceptive pills and the ovarian cycle affect sympathetic nerve activity in healthy women?
Observational (n=23)
Do oral contraceptive pills and the ovarian cycle affect sympathetic nerve activity in healthy women?
Absolute Event Rate: 17.3% vs 25.4%
p-value: p=<0.001
Sympathetic nerve activity varies during the natural ovarian cycle in women, but this modulation is blunted by oral contraceptive pills and is not mediated by changes in baroreflex sensitivity.
Ovarian cycle and OCPs do not alter SNA or baroreflex control in women; challenges animal data translation and leaves open human mechanisms.
Endogenous and exogenous female hormones regulate sympathetic nerve activity (SNA) in animal models, but their impact in humans is controversial. The purpose of this study is to investigate the effects of the ovarian cycle and oral contraceptive pills (OCPs) on SNA. We hypothesized that the effects of endogenous hormones were baroreflex (BR)-mediated and that these cyclical changes in BR control were blunted by OCPs. Furthermore, we hypothesized that the nocturnal fall in blood pressure (BP) ("dipping"), which is sympathetically mediated, also varied with the ovarian cycle. In 23 healthy females (13 OCP users, 10 age-matched, no OCPs), SNA was recorded (microneurography) at rest, during BR activation/deactivation, and cold pressor test (CPT) during low and high hormonal phases. Furthermore, 24-h BP monitoring was performed during low and high hormonal phases. SNA was lower during the low vs. high hormone phase in non-OCP users (17.3 ± 2.4 vs. 25.4 ± 3.2 bursts/min, P < 0.001) but was not different between phases in OCP users [15.5 ± 1.7 vs. 16.6 ± 2.0 bursts/min, P = not significant (NS)]. BR control of SNA was not different during the hormone phases in either group [SNA (total activity/min) mean slope %change from baseline, no OCP users, low vs. high hormone phase 35.4 ± 6.2 vs. 29.6 ± 3.4%, P = NS and OCP users, low vs. high hormone phase 35.7 ± 3.9 vs. 33.5 ± 3.5%, P = NS]. SNA activation during CPT was not impacted by hormonal phase or OCP use. Finally, nondipping was not different between OCP users and nonusers, although there was a trend for nondipping to occur more frequently in the OCP users. SNA varies during the ovarian cycle in women in the absence of OCPs. This modulation cannot be attributed to cyclical changes in the BR sensitivity.
No takes yet. Share an insight, caveat, or question.
Middlekauff et al. (2012) conducted an observational in Healthy (n=23). Oral contraceptive pills (OCPs) vs. Non-OCP users was evaluated on Sympathetic nerve activity (SNA) at rest during low vs. high hormone phase in non-OCP users (bursts/min) (p=<0.001). Sympathetic nerve activity varies during the ovarian cycle in healthy women not using oral contraceptives (17.3 vs 25.4 bursts/min, P<0.001), but this variation is blunted in OCP users.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: